O’Neal Comprehensive Cancer Center awards $530,000 in cancer-related research grants through O’Neal Invests
The O’Neal Comprehensive Cancer Center at UAB is pleased to announce its latest O’Neal Invests grant awards. O’Neal Invests funds UAB investigators initiating new cancer-related projects to do key preliminary work to enable competitive extramural applications.
The sixth grant cycle was last fall. Each application was reviewed by three panel members, who scored it and provided written comments. There were 26 grant applications; 11 applications were discussed during the review panel meeting, and four received a fundable score. The O’Neal Cancer Center received 18 Pre-R01 grant applications and eight Catalyst grant applications. The four awardees are listed below.
Fall 2022 O’Neal Invests Awardees
Department of Medicine, Division of Hematology & Oncology
Heterogeneity of Mutations Dictate Inflammatory Signaling and Subsequent Pre-Leukemic Clonal Dominance
Suzanne Lapi, PhD
Departments of Radiology and Chemistry
Renata Jaskula-Sztul, PhD
Department of Surgery
A Novel Theranostic Approach for Targeting TSH in Thyroid Cancer
Department of Microbiology
Durable Anti-Ovarian Cancer Control via Combinational T-Cell Immunomodulators
Department of Pathology
Fc Gamma Binding Protein (Fcgbp) and Colorectal Adenocarcinoma
Catalyst grants are for $50,000 for one year. Pre-R01 grants are for $160,000 over two years. Both types of grants may have one or more PIs.
There are two O’Neal Invests RFAs per year, in the spring and fall. Cancer Center membership is not a requirement to apply, but awardees must become members. The grants are peer-reviewed by a panel of UAB faculty. Applicants who are not awarded funding receive feedback on their proposals from the review panel and are encouraged to reapply.
Letters of intent for the next round of O’Neal Invests grants are due March 21, 2023. The final grants will be due May 5, 2023.